Evaluation of the albumin-γ-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 3, 2003, Pages 288-295

  Pompili, Maurizio ^a   Addolorato, Giovanni ^a   Pignataro, Giulia ^a   Rossi, Cristina ^a   Zuppi, Cecilia ^a   Covino, Marcello ^a   Grieco, Antonio ^a   Gasbarrini, Giovanni ^a   Rapaccini, Gian Ludovico ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Diagnosis; Hepatocellular carcinoma; Isoenzymes; Liver cirrhosis; glutamyltransferase

Indexed keywords

ALBUMIN; ALBUMIN GAMMA GLUTAMYLTRANSFERASE; ALPHA FETOPROTEIN; GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC ACTIVE HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; ELECTROPHORESIS; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 0037366531     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.02962.x     Document Type: Article

References (52)

1. Tiribelli C, Croce LS, Polo S, Sodde M, Stanta G. Incidence of HCC in Italy. What could we learn from autoptic studies? Ital. J. Gastroenterol. 1991; 23: 448-51.
2. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 1987; 47: 4967-72.
3. Colombo M, De Franchis R, del Ninno E et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N. Engl. J. Med. 1991; 325: 675-80.
4. Benvegnu L, Fattovich G, Noventa F et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994; 74: 2441-8.
5. Taketa K. Alpha-fetoprotein: reevaluation in hepatology. Hepatology 1990; 12: 1420-31.
6. Colombo M, Kuo G, Choo QL et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1006-8.
7. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994; 19: 61-6.
8. Cottone M, Turri M, Caltagirone M et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alpha-fetoprotein. J. Hepatol. 1994; 21: 1029-34.
9. Johnson PJ, Leung N, Cheng P et al. Hepatoma-specific alpha-fetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease. Br. J. Cancer 1997; 75: 236-40.
10. Johnson PJ, Poon TCW, Hjelm NM, Ho CS, Blake C, Ho SKW. Structures of disease-specific serum alpha-fetoprotein isoforms. Br. J. Cancer 2000; 83: 1330-7.
11. Giardina MG, Matarazzo M, Variale A, Morante R, Napoli A, Martino R. Serum Alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma. Cancer 1992; 70: 1044-8.
12. Liebman HA, Furie BC, Tong MJ et al. Des-gamma-carboxy (abnormal) prothrombinas a serum marker of primary hepatocellular carcinoma. N. Engl. J. Med. 1984; 310: 427-31.
13. Takikawa Y, Suzuki K, Yamazaki K et al. Plasma abnormal prothrombin (PIVKA-II): a new and reliable marker for the detection of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1992; 7: 1-6.
14. Saitoh S, Ikeda K, Koida I et al. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas. Cancer 1994; 74: 2918-23.
15. Okuda H, Nakanishi T, Takatsu K et al. Measurement of serum levels of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity. Cancer 1999; 85: 812-18.
16. Albert Z, Orlowski M, Szewczuk A. Histochemical demonstration of gamma-glutamyl transpeptidase. Nature 1961; 191: 767-8.
17. Albert Z, Rzucidlo Z, Starzyk H. Comparative biochemical and histochemical studies of the activities of gamma-glutamyl transpeptidase in the organs of fetuses, new borns and adult rats. Acta Histochem. 1970; 37: 34-9.
18. Fiala S, Fiala AE, Dixon B. Gamma-glutamyl transpeptidase in transplantable, chemically-induced rat hepatomas and 'spontaneous' mouse hepatomas. J. Natl Cancer Inst. 1972; 48: 1393-401.
19. Fiala S, Fiala ES. Activation by chemical carcinogens of gamma-glutamyl transpeptidase in rat and mouse liver. J. Natl Cancer Inst. 1973; 51: 151-8.
20. Kalengayi MMR, Ronchi G, Desmet VJ. Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis. J. Natl Cancer Inst. 1975; 55: 579-88.
21. Kew MC, Wolf P, Whittaker D, Rowe P. Tumour-associated isoenzymes of gamma-glutamyl transferase in the serum of patients with hepatocellular carcinoma. Br. J. Cancer 1984; 50: 451-5.
22. Castaldo G, Intrieri M, Castellano L et al. Serum gamma-glutamyltransferase isoform complexed to LDL in the diagnosis of small hepatocellular carcinoma. Clin. Chem. 1999; 45: 1100-1.
23. Kojima J, Kanatani N, Nakamura N, Kashiwagi T, Tohjoh F, Akiyama M. Electrophoretic fractionation of serum gamma-glutamyl transpeptidase in human hepatic cancer. Clin. Chem. Acta 1980; 106: 165-72.
24. Suzuki H. Clinical significance of appearance of serum gamma-glutamyl transpeptidase isoenzyme. Gastroenterol. Jpn 1981; 16: 122-8.
25. Sawabu N, Nakagen M, Ozaki K et al. Clincal evaluation of specific gamma-GTP isoenzymes in patients with hepatocellular carcinoma. Cancer 1983; 51: 327-31.
26. Xu K, Meng XY, Wu JW, Shen B, Shi YC, Wei Q. Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study. Am. J. Gastroenterol. 1992; 87: 991-5.
27. Yao DF, Huang ZW, Chen SZ et al. Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyl transferase. Am. J. Clin. Pathol. 1998; 110: 743-9.
28. Sacchetti L, Castaldo G, Fortunato G, Salvatore F. Improved procedure for measuring gamma-glutamyltransferase isoenzymes in serum. Clin. Chem. 1988; 34: 419-22.
29. Sacchetti L, Castaldo G, Salvatore F. The gamma-glutamyltransferase isoenzyme pattern in serum as a signal discriminating between hepatobiliary diseases, including neoplasia. Clin. Chem. 1988; 34: 352-5.
30. Sacchetti L, Castaldo G, Cimino L, Budillon G, Salvatore F. Diagnostic efficiency in discriminating liver malignancies from cirrhosis by serum gamma-glutamyltransferase isoforms. Clin. Chem. Acta 1988; 177: 167-72.
31. Sacchetti L, Castaldo G, Salvatore F. Electrophoretic behaviour and partial characterization of disease associated serum forms of gamma-glutamyltransferase. Electrophoresis 1989; 10: 619-27.
32. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding esophageal varices. Br. J. Surg. 1973; 60: 646-9.
33. Tao LC, Ho CS, McLoughlin MJ, Evans WK, Donat EE. Cytologic diagnosis of hepatocellular carcinoma by fine-needle aspiration biopsy. Cancer 1984; 53: 547-52.
34. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases amomg 48,900 necropsies. Cancer 1954; 7: 462-503.
35. Meyts ERD, Heisterkamp N, Groffen J. Cloning and nucleotide sequence of human gamma-glutamyl transpeptidase. Proc. Natl Acad. Sci. USA 1988; 85: 8840-4.
36. Stefanini GF, Addolorato G, Caputo F, Olanda S, Gasbarrini G. Can the gamma-glutamyl transpeptidase isoforms really be utilized in the diagnosis of alcoholic liver disease? Alcohol Alcohol. 1998; 33: 92-3.
37. Bellini M, Tumino E, Giordani R et al. Serum gamma-glutamyl transpeptidase isoforms in alcoholic liver disease. Alcohol Alcohol. 1997; 32: 259-66.
38. Nemesanzky E, Lott JA. Gamma-glutamyltransferase and its isoenzymes: progress and problems. Clin. Chem. 1985; 31: 797-803.
39. Wenham PR, Horn DB, Smith AF. Multiple forms of GGT: a clinical study. Clin. Chem. 1985; 31: 569-73.
40. Yao D, Jiang D, Huang Z et al. Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of the gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer 2000; 88: 761-9.
41. Kottgen E, Reutter W, Gerok W. Two different gamma-glutamyltransferases during development of liver and small intestine: a fetal (sialo-) and an adult (asialo-) glycoprotein. Biochem. Biophys. Res. Comm. 1976; 72: 61-6.
42. Cedrone A, Covino M, Caturelli E et al. Utility of serum α-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 Western patients. Hepatogastroenterology 2000; 47: 1654-8.
43. Sheu JC, Sung JL, Chen DS et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985; 89: 259-66.
44. Sonoda K, Shirabe K, Takenaka K, Kanematsu T, Yasumori K, Sugimachi K. Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow up and treatment. Hepatology 1989; 10: 1003-7.
45. Okuda K. The liver cancer Study Group of Japan: primary liver cancer in Japan. Cancer 1980; 45: 2663-9.
46. The liver cancer Study Group of Japan. Survey and follow up of primary liver cancer in Japan. Acta Hepatol. Jpn 1993; 34: 805-13.
47. Furui J, Furukawa M, Kanematsu T. The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma. Hepatogastroenterology 1995; 42: 445-9.
48. Sherman M. Alphafetoprotein: an obituary. J. Hepatol. 2001; 34: 603-5.
49. Trevisani F, D'Intino PE, Morselli-Labate AM et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HbsAg and anti-HCV status. J. Hepatol. 2001; 34: 570-5.
50. Ishii M, Gama H, Chida N et al. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. Am. J. Gastroenterol. 2000; 95: 1036-40.
51. Kondo F, Wada K, Nagato Y et al. Biopsy diagnosis of well-differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology 1989; 9: 751-5.
52. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.